Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection-Reference-Cited by-同舟云学术

Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection

Published:2010-07-01 Issue:7 Volume:5 Page:e11416
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Grant Philip M.,Komarow Lauren,Andersen Janet,Sereti Irini,Pahwa Savita,Lederman Michael M.,Eron Joseph,Sanne Ian,Powderly William,Hogg Evelyn,Suckow Carol,Zolopa Andrew

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference21 articles.

1. Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.;A Mocroft;Lancet,1998

2. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.;FJ Palella;N Engl J Med,1998

3. Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.;EM Race;Lancet,1998

4. Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients.;N Foudraine;AIDS,1999

5. Determinants of immune reconstitution inflammatory syndrome in HIV type-1 infected patients with tuberculosis after initiation of antiretroviral therapy.;G Breton;Clin Infect Dis,2004

Cited by 128 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical illness due to infection in people living with HIV;The Lancet HIV;2024-06

2. Severe BCG immune reconstitution inflammatory syndrome lymphadenitis successfully managed with pre-antiretroviral counseling and a non-surgical approach: a case report;AIDS Research and Therapy;2024-04-27

3. Rapid ART initiation with bictegravir/emtricitabine/tenofovir alafenamide in individuals presenting with advanced HIV disease (Rainbow study);International Journal of Antimicrobial Agents;2024-01

4. Integrase inhibitors: current protagonists in antiretroviral therapy;Immunotherapy;2023-12

5. Cryptococcal meningitis;Nature Reviews Disease Primers;2023-11-09